Navigation Links
Signature Homes Partners With St. Jude Children's Research Hospital Through Volunteer Opportunities, Fundraising and a St. Jude Dream Home Giveaway
Date:11/26/2013

BIRMINGHAM, Ala., Nov. 26, 2013 /PRNewswire-iReach/ -- Signature Homes, one of America's largest home building companies, has begun a partnership with St. Jude Children's Research Hospital.  St. Jude has been pioneering research and treatment for catastrophic childhood diseases since being founded by the late entertainer Danny Thomas in 1962.  The partnership between the home builder and the hospital will equip doctors and researchers with much needed funds and resources for future innovation and development. 

The largest aspect of this new partnership is the construction of a new home in Signature's Nashville, TN market.  This home will be donated to the hospital for their 2014 St. Jude Dream Home Giveaway campaign.  This campaign is one of the largest single-event fundraisers for St. Jude nationwide and has raised more than $270 million dollars.  The home will be constructed in one of Signature Homes' newest new home communities, Carothers Cove at Ladd Park, located just outside of Nashville in Franklin, TN. 

In addition to the donation of the St. Jude Dream Home house, Signature Homes' communities, families and residents will join together throughout the year in continued support of St. Jude.  Events will be held in each Signature Home community, and volunteer teams will be created to travel to St. Jude in Memphis throughout the year.  "Signature Homes believes in family, that's why we're in the business of building places where families can live out their dreams.  Now it's time for our Signature families to support others in their time of greatest need," said Dwight Sandlin, CEO of Signature Homes. 

Due to extensive research, like that done at St. Jude, 5-year cancer survival rates have dramatically increased since the hospital's inception.  One of the largest successes has been in acute lymphoblastic leukemia (cancer of the blood), which has gone from a 4% to a 94% 5-year cancer survival rate.  "The amount of kid's that have a brighter tomorrow because of the work done at St. Jude is incredible, and we believe so much in what they do.  That is why we want to become one of their biggest supporters," said Sandlin. 

For more information on the Signature Homes, and their efforts in support of St. Jude, please call (205) 983-2455 or visit www.e-signaturehomes.com

Media Contact: Brian McDuff, Signature Homes, 205-983-2455, bmcduff@e-signaturehomes.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Signature Homes
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Signature Therapeutics, Inc., Presents Four Scientific Posters Today at PAINWeek 2013 Meeting
2. Senator Shares Insight on Florida Physician Dispensing Legislation as First Guest of Progressive Medicals New SignatureSeries
3. Signature Therapeutics Receives BrIDGs Award to Advance Its Abuse-Deterrent Oxycodone, PF614
4. CLAAD Lauds Signature Therapeutics R&D Efforts To Reduce Prescription Drug Abuse
5. Wacoms New DTU-1031 Provides Paperless Electronic Signature Solution for Businesses
6. H. D. Smith Supports Local Hospitals, Nursing Homes, Clinics And Independent Retail Pharmacies Throughout Hurricane Sandy
7. Stakeholders elect ex-officio members to Board of Pennsylvania eHealth Partnership Authority
8. Highmark executive Michael Fiaschetti Appointed to Board of Pennsylvania eHealth Partnership Authority
9. Richard Wolf USA And MAQUET Launch OR Integration Sales Partnership
10. Eisai Joins Groundbreaking Tuberculosis Drug Accelerator Partnership to Discover New Tuberculosis Drugs
11. GENCO Partners with TECSYS to Deliver Best-in-Class Solutions to Health Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , June 26, 2016 One of Australia,s ... announced the formation of a new biotechnology company, Noxopharm Limited [ABN ... in an IPO and to list on the ASX. ... NOX66, ready to enter a Phase 1 clinical study later this ... to address one of the biggest problems facing cancer patients - ...
(Date:6/26/2016)... DUBLIN , June 27, 2016 Jazz ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act ... proposed acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... 11:59 p.m. (Eastern Daylight Time). As previously ... entered into a definitive merger agreement under which Jazz ...
(Date:6/26/2016)... 27, 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ... whatever measures required to build a strong and stable ... currently listed on the OTC Markets-pink current trading platform. ... CEO, "We are seeing an anomaly in market trading ... only by the Company, but shareholders and market players ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced today its affiliation with Tennessee Counseling Association. This new relationship ... of the Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA ...
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... Charlotte, NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind ... able to be personalized through a fitness app. The fitness app plans to fix the ... solutions currently only offer a one size fits all type program , They ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 ... brings up a new, often overlooked aspect of head lice: the parasite’s ability to live ... not a common occurrence, but a necessary one in the event that lice have simply ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):